Here, our study, using recombinant adeno-associated virus serotype 9 (rAAV9) to cardiac-specifically knock down Bhlhe40, is the first to demonstrate a direct relationship between the augmented expression of Bhlhe40 in atrial cardiomyocytes and patients with AF. Here, BHLHE40 is linked to atrial fibrillation.